Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02078284 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
A Phase 1 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT02078284 is a Phase 1 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 28 participants.
The verdict
NCT02078284, a Phase 1 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study is to evaluate the safety of intravenous (IV) infusion of dimethyl sulfoxide (DMSO) cryopreserved platelets (CPP) in participants with World Health Organization (WHO) Grade 2 bleed in spite of receiving a transfusion of liquid stored platelets (LSP) in the past 48 hours by collecting adverse events (AEs) and by evaluating coagulation-related parameters to assess the evidence of any thrombotic events after CPP or LSP transfusion.
Interventions
- BIOLOGICAL CPP
- BIOLOGICAL LSP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-11-05 |
| Est. Completion | 2016-07-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02078284
The ClinicalTrials.gov registry entry for NCT02078284 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CPP is the first listed.
NCT02078284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02078284 about?
NCT02078284 is a clinical study titled "Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets". This study is to evaluate the safety of intravenous (IV) infusion of dimethyl sulfoxide (DMSO) cryopreserved platelets (CPP) in participants with World Health Organization (WHO) Grade 2 bleed in spite of receiving a transfusion of liquid stored platelets (LSP) in the past 48 hours by collecting adve...
What is the current status of trial NCT02078284?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2014-11-05. Estimated completion is 2016-07-17.
What interventions are being tested in trial NCT02078284?
The interventions under investigation include: CPP (BIOLOGICAL), LSP (BIOLOGICAL).
Who is sponsoring clinical trial NCT02078284?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.